Loading clinical trials...
Loading clinical trials...
This study will prospectively evaluate a new electrosurgical procedure (bipolar transurethral prostatectomy) in men with symptomatic benign prostatic hyperplasia.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborators
NCT05574244 · Benign Prostatic Hyperplasia
NCT03297281 · Benign Prostatic Hyperplasia, Anticoagulant Adverse Reaction
NCT07016620 · Benign Prostatic Hyperplasia (BPH)
NCT07377929 · Benign Prostatic Hypertrophy (BPH), Lower Urinary Track Symptoms
NCT06312722 · Benign Prostatic Hyperplasia
Alberta Urology Institute Research Centre
Edmonton, Alberta
Prostate Centre at Vancouver General Hospital
Vancouver, British Columbia
Can-Med Clinical Research Inc
Victoria, British Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions